You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mismatched unrelated donor

Showing 1 - 25 of 3,869
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

Recruiting
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
  • Standard of Care Chemotherapy
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

GVHD Trial in Detroit (uhCG/EGF)

Recruiting
  • Graft Versus Host Disease
  • Detroit, Michigan
    Henry Ford Hospital
Dec 23, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
Dec 8, 2021

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bone Marrow Hematopoeitic Cell Transplant (HCT)
  • +9 more
  • (no location specified)
Sep 27, 2021

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,

Not yet recruiting
  • End Stage Kidney Disease
  • +3 more
  • Donor CD34+, CD3+. and belumosudil
  • Los Angeles, California
    University of California, Los Angeles
Apr 6, 2023

Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,

Completed
  • Myelodysplastic Syndrome (MDS)
  • +6 more
  • Gainesville, Florida
  • +10 more
Nov 30, 2020

Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,

Completed
Has Results
  • Acute Myeloid Leukemia
  • Advanced Myelodysplastic Syndromes
  • Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 27, 2021

Myeloid Malignancies Trial in Italy (GvHD prophylaxis)

Recruiting
  • Myeloid Malignancies
  • GvHD prophylaxis
  • Alessandria, Italy
  • +32 more
Nov 23, 2022

AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

Recruiting
  • AML - Acute Myeloid Leukemia
  • +5 more
  • T-allo10
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

Completed
  • Severe Aplastic Anemia
  • Bone Marrow Failure Syndromes
  • Bone marrow transplant
  • +7 more
  • Baltimore, Maryland
  • +1 more
Feb 10, 2022

Immunodeficiencies Trial in Philadelphia (CliniMACs)

Active, not recruiting
  • Immunodeficiencies
  • CliniMACs
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 1, 2022

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
Has Results
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)

Recruiting
  • Chronic Granulomatous Disease
  • CGD
  • JSP191
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 5, 2023

Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

Completed
  • Haematological Malignancies
  • CD25/71 allodepleted donor T-cells
  • London, United Kingdom
  • +1 more
Jul 18, 2022

Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions Trial (HSCT Arm group)

Not yet recruiting
  • Idiopathic Aplastic Anemia
  • +2 more
  • HSCT Arm group
  • (no location specified)
Jun 10, 2022

Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,

Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
  • +1 more
Aug 20, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Severe Aplastic Anemia Trial in Boston, Salt Lake City (drug, procedure, radiation)

Recruiting
  • Severe Aplastic Anemia
  • Boston, Massachusetts
  • +1 more
Jan 13, 2023

Samples and Data for National Marrow Donor Program Repository

Recruiting
  • Bone Marrow Transplantation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 1, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +16 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 1, 2022

    Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

    Not yet recruiting
    • Acute Leukemia
    • +4 more
    • Haploidentical hematopoietic cell transplantation (haploHCT)
    • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
    • (no location specified)
    Jul 13, 2022